Concepts (99)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Immunotherapy, Adoptive | 5 | 2022 | 1017 | 0.990 |
Why?
|
| Interleukin-7 | 2 | 2017 | 149 | 0.670 |
Why?
|
| T-Lymphocytes | 5 | 2018 | 10362 | 0.520 |
Why?
|
| Cytokines | 3 | 2018 | 7189 | 0.490 |
Why?
|
| Receptors, Antigen, T-Cell | 6 | 2022 | 2498 | 0.400 |
Why?
|
| Neuroblastoma | 1 | 2017 | 1180 | 0.380 |
Why?
|
| Combined Modality Therapy | 1 | 2018 | 8896 | 0.280 |
Why?
|
| Glioblastoma | 1 | 2017 | 3344 | 0.230 |
Why?
|
| Chylothorax | 1 | 2022 | 90 | 0.220 |
Why?
|
| Lymphatic Abnormalities | 1 | 2022 | 130 | 0.210 |
Why?
|
| Biliary Tract | 1 | 2021 | 139 | 0.200 |
Why?
|
| Hydrodynamics | 1 | 2021 | 147 | 0.200 |
Why?
|
| Pleural Effusion | 1 | 2022 | 340 | 0.190 |
Why?
|
| Chimera | 1 | 2018 | 477 | 0.160 |
Why?
|
| Hepatitis B Surface Antigens | 1 | 2018 | 288 | 0.160 |
Why?
|
| Receptors, Cytokine | 1 | 2017 | 253 | 0.150 |
Why?
|
| Epstein-Barr Virus Infections | 1 | 2022 | 534 | 0.150 |
Why?
|
| Viral Envelope Proteins | 1 | 2020 | 589 | 0.150 |
Why?
|
| Neoplasms | 3 | 2022 | 20172 | 0.150 |
Why?
|
| Adoptive Transfer | 1 | 2018 | 874 | 0.140 |
Why?
|
| Hepatitis B virus | 1 | 2018 | 444 | 0.130 |
Why?
|
| Cytomegalovirus Infections | 1 | 2020 | 753 | 0.130 |
Why?
|
| Salmonella enteritidis | 1 | 2013 | 18 | 0.130 |
Why?
|
| Lectins, C-Type | 1 | 2017 | 617 | 0.130 |
Why?
|
| Drug Carriers | 1 | 2018 | 715 | 0.120 |
Why?
|
| Aneurysm, Infected | 1 | 2013 | 84 | 0.120 |
Why?
|
| Xenograft Model Antitumor Assays | 2 | 2017 | 3714 | 0.110 |
Why?
|
| Salmonella Infections | 1 | 2013 | 182 | 0.110 |
Why?
|
| Silver Nitrate | 1 | 2010 | 13 | 0.110 |
Why?
|
| Alkenes | 1 | 2010 | 62 | 0.100 |
Why?
|
| Aneurysm, False | 1 | 2013 | 284 | 0.100 |
Why?
|
| Antigens, Neoplasm | 1 | 2017 | 2003 | 0.090 |
Why?
|
| Spectrometry, Mass, Electrospray Ionization | 1 | 2010 | 293 | 0.090 |
Why?
|
| Immunotherapy | 3 | 2022 | 4057 | 0.090 |
Why?
|
| Immunologic Factors | 1 | 2018 | 1578 | 0.090 |
Why?
|
| T-Lymphocyte Subsets | 1 | 2017 | 1924 | 0.090 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2017 | 3878 | 0.090 |
Why?
|
| Tumor Microenvironment | 1 | 2018 | 2987 | 0.080 |
Why?
|
| Nanoparticles | 1 | 2018 | 2048 | 0.070 |
Why?
|
| Liver | 2 | 2021 | 7622 | 0.070 |
Why?
|
| Antiviral Agents | 1 | 2018 | 2768 | 0.070 |
Why?
|
| Signal Transduction | 2 | 2018 | 23950 | 0.060 |
Why?
|
| Animals | 8 | 2022 | 170486 | 0.060 |
Why?
|
| Cell Line, Tumor | 2 | 2017 | 16959 | 0.060 |
Why?
|
| Mice | 6 | 2022 | 80876 | 0.060 |
Why?
|
| Cytotoxicity, Immunologic | 2 | 2017 | 1499 | 0.060 |
Why?
|
| Thoracic Duct | 1 | 2022 | 56 | 0.060 |
Why?
|
| Leukemia, Myeloid, Acute | 1 | 2017 | 3281 | 0.060 |
Why?
|
| Lymphography | 1 | 2022 | 178 | 0.060 |
Why?
|
| Cell Proliferation | 1 | 2017 | 10803 | 0.050 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2017 | 8638 | 0.050 |
Why?
|
| T-Cell Antigen Receptor Specificity | 1 | 2017 | 93 | 0.040 |
Why?
|
| Hep G2 Cells | 1 | 2018 | 397 | 0.040 |
Why?
|
| Interleukin-15 | 1 | 2017 | 166 | 0.040 |
Why?
|
| Virion | 1 | 2018 | 418 | 0.040 |
Why?
|
| Herpesvirus 4, Human | 1 | 2022 | 1241 | 0.040 |
Why?
|
| Humans | 9 | 2022 | 708843 | 0.040 |
Why?
|
| Gene Transfer Techniques | 1 | 2021 | 1299 | 0.040 |
Why?
|
| Mice, Inbred NOD | 1 | 2020 | 1918 | 0.030 |
Why?
|
| Hepatitis B, Chronic | 1 | 2018 | 343 | 0.030 |
Why?
|
| Fetal Blood | 1 | 2020 | 1334 | 0.030 |
Why?
|
| Ceftriaxone | 1 | 2013 | 149 | 0.030 |
Why?
|
| Myeloid Cells | 1 | 2017 | 787 | 0.030 |
Why?
|
| Immunophenotyping | 1 | 2017 | 1908 | 0.030 |
Why?
|
| Urine | 1 | 2013 | 385 | 0.030 |
Why?
|
| Swine | 1 | 2021 | 5763 | 0.030 |
Why?
|
| Isomerism | 1 | 2010 | 207 | 0.030 |
Why?
|
| Antibodies, Neutralizing | 1 | 2020 | 1796 | 0.020 |
Why?
|
| Blood | 1 | 2013 | 624 | 0.020 |
Why?
|
| HEK293 Cells | 1 | 2020 | 4310 | 0.020 |
Why?
|
| Interleukin-2 | 1 | 2017 | 1936 | 0.020 |
Why?
|
| Radiography, Abdominal | 1 | 2013 | 585 | 0.020 |
Why?
|
| Pelvis | 1 | 2013 | 685 | 0.020 |
Why?
|
| Inflammation Mediators | 1 | 2017 | 1948 | 0.020 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2020 | 4383 | 0.020 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2020 | 4254 | 0.020 |
Why?
|
| Flow Cytometry | 1 | 2017 | 6127 | 0.020 |
Why?
|
| Lymphocyte Activation | 1 | 2017 | 5908 | 0.020 |
Why?
|
| Dogs | 1 | 2010 | 4059 | 0.020 |
Why?
|
| Urinary Bladder | 1 | 2010 | 1125 | 0.020 |
Why?
|
| Gene Expression | 1 | 2017 | 8014 | 0.020 |
Why?
|
| Fatty Acids | 1 | 2010 | 1741 | 0.010 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2020 | 5135 | 0.010 |
Why?
|
| Lipid Metabolism | 1 | 2010 | 1999 | 0.010 |
Why?
|
| Cell Differentiation | 1 | 2017 | 11718 | 0.010 |
Why?
|
| Lipids | 1 | 2010 | 3246 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2017 | 18375 | 0.010 |
Why?
|
| Anti-Bacterial Agents | 1 | 2013 | 6991 | 0.010 |
Why?
|
| Aged | 2 | 2017 | 161488 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2017 | 58184 | 0.010 |
Why?
|
| Young Adult | 1 | 2017 | 55940 | 0.010 |
Why?
|
| Child | 1 | 2017 | 73636 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2013 | 20308 | 0.010 |
Why?
|
| Adolescent | 1 | 2017 | 84718 | 0.010 |
Why?
|
| Male | 2 | 2017 | 349524 | 0.000 |
Why?
|
| Treatment Outcome | 1 | 2013 | 61932 | 0.000 |
Why?
|
| Adult | 1 | 2017 | 211041 | 0.000 |
Why?
|
| Middle Aged | 1 | 2017 | 213752 | 0.000 |
Why?
|
| Female | 1 | 2017 | 375205 | 0.000 |
Why?
|
Concepts
(99)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(6)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_